Shi Hu

7PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyBiologically active moleculesRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 20, 2025
T-Cell-Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS-CoV-2 Infection.

Wenyan Fu, Wei Zhang, Zhongshuai You

|Jun 06, 2022
Synthetic libraries of immune cells displaying a diverse repertoire of chimaeric antigen receptors as a potent cancer immunotherapy.

Wenyan Fu, Changhai Lei, Chuqi Wang

|Nov 12, 2021
Therapeutic antibodies under development for SARS-CoV-2.

Zetong Ma, MengMei Zhu, Shuyi Zhang

|Jun 18, 2020
Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic.

Kewen Qian, Shi Hu

|Apr 26, 2020
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.

Changhai Lei, Kewen Qian, Tian Li

|Mar 10, 2018
Cardiac adenovirus-associated viral Presenilin 1 gene delivery protects the left ventricular function of the heart via regulating RyR2 function in post-ischaemic heart failure.

Tian Li, Yafeng Shen, Li Su

Pageof 2

Frequent Collaborators

1 joint publications

Changhai Lei